Business Context and Reporting Period
This Form 8-K filing by Gossamer Bio, Inc. (GOSS) is dated July 18, 2024. The report addresses a regulatory event concerning the company's listing status on the Nasdaq Global Select Market.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on a corporate governance and listing compliance event.
Material Changes
The primary material change reported is the resolution of a listing deficiency. On July 18, 2024, the company received confirmation from Nasdaq that it has regained compliance with the minimum bid price requirement (Rule 5450(a)(1)). This resolves a non-compliance issue previously notified on May 22, 2024, where the stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days.
Guidance, Outlook, and Risks
The filing contains no financial guidance, forward-looking outlook, or management commentary regarding business operations. The only risk addressed is the prior risk of delisting due to low stock price, which has now been mitigated as the matter is closed.
Investor Verification Checklist
- Verify the current trading price of GOSS to ensure it remains above the $1.00 minimum bid price threshold.
- Confirm the status of the Nasdaq listing on the Nasdaq Global Select Market.
- Review the May 22, 2024, notification details to understand the duration of the prior non-compliance period.